These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


163 related items for PubMed ID: 5865328

  • 1. The influence of corticotherapy on the blood proteolytic activity in viral hepatitis.
    Gibiński K, Gonciarz Z, Mandecki T, Fojt E, Maraszek J.
    Arch Immunol Ther Exp (Warsz); 1965; 13(6):639-44. PubMed ID: 5865328
    [No Abstract] [Full Text] [Related]

  • 2. [Apropos of corticoid therapy of acute viral hepatitis at the early phase].
    Laverdant C, Molinié C, Essioux H, Daly JP.
    Gastroenterol Clin Biol; 1978; 2(6-7):652-3. PubMed ID: 680487
    [No Abstract] [Full Text] [Related]

  • 3. [Action of corticoid therapy on the glucocorticoid steroid hormone balance in epidemic hepatitis].
    Buşilă VT, Dragomirescu M, Marţincu V, Dragomirescu L.
    Med Interna (Bucur); 1971 Mar; 23(3):335-40. PubMed ID: 5574930
    [No Abstract] [Full Text] [Related]

  • 4. [The pros and cons of corticotherapy in viral hepatitis].
    Biron A.
    Therapeutique; 1973 Feb; 49(2):149-51. PubMed ID: 4732778
    [No Abstract] [Full Text] [Related]

  • 5. Corticotherapy of viral hepatitis in the light of enzymologic studies.
    Drozdz H, Jedrychowski A, Zasowska K, Szreniawska T, Wojcik Z, Baniowski A, Biernacka B.
    Acta Med Pol; 1969 Feb; 10(1):137-50. PubMed ID: 5784092
    [No Abstract] [Full Text] [Related]

  • 6. The effect of corticotherapy on fibrinolysis in viral hepatitis.
    Nowak A, Woźniak M, Fojt E.
    Pol Med J; 1969 Feb; 8(2):336-42. PubMed ID: 5772793
    [No Abstract] [Full Text] [Related]

  • 7. [Why corticotherapy in common viral hepatitis is contraindicated].
    Heully F, Gaucher P, Jeanperrre R.
    Sem Hop Ther; 1974 Feb; 50(2):129-31. PubMed ID: 4439012
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Diabetogenic effects of corticotherapy in viral hepatitis patients].
    Borzuchowska A, Modzelewski T.
    Przegl Epidemiol; 1965 Feb; 19(2):194-5. PubMed ID: 5883554
    [No Abstract] [Full Text] [Related]

  • 12. [Thoughts on the treatment of viral hepatitis (apropos of 455 cases)].
    Roux M, Fritz A, Marion J, Mériaux J, Antiglio W.
    J Med Bord; 1966 Apr; 143(4):493-503. PubMed ID: 5933471
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Short-term alternating corticotherapy with single doses at 48 hour intervals in acute viral hepatitis].
    Căruntu F, Angelescu C, Predoviciu F.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976 Apr; 28(3):205-10. PubMed ID: 7827
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Recovery under corticotherapy of cirrhogenic viral hepatitis; optical & electronic microscopic control].
    TURPIN R, DARNIS F, LAFOURCADE J.
    Sem Hop; 1957 Nov 30; 33(68/11):3992-8P. PubMed ID: 13506630
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.